Breaking News

GLOBE-NEWSWIRE

Auto Added by WPeMatico

ROSEN, LEADING INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HUMA

NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Humacyte, Inc. (NASDAQ: HUMA) between May 10, 2024 and October 17, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has […]

Read More »

High-impact oil and gas exploration could cut global scope 1 and 2 emissions by 6% in 2030

Without creating new demand, new discoveries can help curb emissions, drive value for the industry LONDON and HOUSTON and SINGAPORE, Nov. 21, 2024 (GLOBE NEWSWIRE) — Investment in oil and gas exploration has plummeted two-thirds in the last decade, but the industry still has a critical role to play in decarbonisation efforts and providing advantaged […]

Read More »

CGTN: ‘Golden partners’: China, Brazil seek a more just world, sustainable planet

BEIJING, Nov. 21, 2024 (GLOBE NEWSWIRE) — CGTN publishes an article on China and Brazil’s plans to seek a more just world and a sustainable planet. In 2014, the cooperation agreement between China and Brazil on the Belo Monte UHV transmission project was signed. The mega-project traverses a vast area, stretching more than 2,000 kilometers […]

Read More »

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – November 20, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will participate in the […]

Read More »

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discovery Recursion will host an update […]

Read More »

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elanco Animal Health Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELAN

NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Elanco Animal Health Incorporated (NYSE: ELAN) between November 7, 2023 and June 26, 2024, both dates inclusive (the “Class Period”), of the important December 6, 2024 lead plaintiff deadline. SO WHAT: If you purchased Elanco […]

Read More »

LLAP DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Terran Orbital Corporation Investors to Secure Counsel Before Important November 26 Deadline in Securities Class Action – LLAP

NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Terran Orbital Corporation (NYSE: LLAP) between August 15, 2023 and August 14, 2024, both dates inclusive (the “Class Period”), of the important November 26, 2024 lead plaintiff deadline. SO WHAT: If you purchased Terran securities […]

Read More »